US Broker Ratings

Domo, Inc. (DOMO) Investor Outlook: Analyzing the 189% Potential Upside

Domo, Inc. (NASDAQ: DOMO), a player in the technology sector specializing in application software, offers investors an intriguing opportunity with a tantalizing potential upside of 189.02%. Despite its modest market..

Cartesian Therapeutics, Inc. (RNAC) Stock Analysis: Exploring a 420% Potential Upside in Biotechnology

Investors with an eye on the healthcare sector, particularly those interested in cutting-edge biotechnology, should take note of Cartesian Therapeutics, Inc. (RNAC). This U.S.-based clinical-stage biotech firm is making significant..

SANUWAVE Health, Inc. (SNWV) Investor Outlook: Exploring a Potential 109.55% Upside

SANUWAVE Health, Inc. (SNWV), a key player in the healthcare sector’s medical devices industry, presents a compelling investment case for those intrigued by the potential of regenerative medicine technologies. Specializing..

Silvaco Group, Inc. (SVCO) Stock Analysis: Unpacking a Potential 142.97% Upside

Silvaco Group, Inc. (SVCO), a leading player in the technology sector specializing in software applications, presents an intriguing opportunity for investors. Headquartered in Santa Clara, California, Silvaco operates in providing..

CytomX Therapeutics, Inc. (CTMX) Investor Outlook: Exploring a 58.73% Potential Upside Amid Innovative Oncology Developments

CytomX Therapeutics, Inc. (NASDAQ: CTMX) is garnering attention in the biotechnology sector with its novel approach to oncology therapeutics. Based in South San Francisco, California, the company is leveraging conditionally..

HubSpot, Inc. (HUBS) Investor Outlook: A Compelling 117.88% Potential Upside Amid Market Volatility

As a pivotal player in the Technology sector, particularly within the Software – Application industry, HubSpot, Inc. (NYSE: HUBS) presents itself as an intriguing opportunity for investors. Headquartered in Cambridge,..

Materialise NV (MTLS) Stock Analysis: Exploring a 66% Potential Upside in the 3D Printing Space

Materialise NV (NASDAQ: MTLS), a leading player in the 3D printing sector, offers a compelling investment story for those looking to capitalize on the burgeoning field of additive manufacturing. With..

Marti Technologies, Inc. (MRT): Investor Outlook Highlights 150% Potential Upside

Marti Technologies, Inc. (MRT), a Turkish innovator in urban transportation, is capturing investor interest with its promising growth potential and a striking 150% upside as per analyst ratings. As the..

Phathom Pharmaceuticals (PHAT) Stock Analysis: A Potential 73% Upside in the Biotech Space

Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is making waves in the biotechnology sector, capturing the attention of individual investors with its promising portfolio and substantial growth potential. Based in Florham Park,..

Aurora Cannabis Inc. (ACB): Investor Outlook with a Promising 69.98% Upside Potential

Aurora Cannabis Inc. (ACB), a leading player in the healthcare sector, stands at a pivotal point, with its stock currently priced at $3.75 USD. Operating within the niche of Drug..

Yalla Group Limited (YALA) Stock Analysis: Potential 40% Upside Makes This UAE Tech Firm Worth Watching

Yalla Group Limited (YALA), a Dubai-based technology company, has been capturing investor attention with its social networking and gaming platform tailored for the Middle East and North Africa (MENA) region...

Arcturus Therapeutics Holdings (ARCT) Stock Analysis: A Biotech Gem with 357% Upside Potential

Arcturus Therapeutics Holdings Inc. (ARCT), a San Diego-based biotechnology company, is sparking interest among investors due to its promising development pipeline and significant potential upside. Specializing in mRNA-based therapeutics, Arcturus..

Neuronetics, Inc. (STIM) Stock Analysis: Exploring a Potential 319% Upside in the Medical Devices Sector

Neuronetics, Inc. (NASDAQ: STIM) is capturing attention in the healthcare sector, particularly within the medical devices industry, due to its innovative approach to treating major depressive disorder (MDD). Known for..

Benitec Biopharma Inc. (BNTC) Stock Analysis: Healthcare Innovator with a 92% Potential Upside

Benitec Biopharma Inc. (NASDAQ: BNTC) stands out in the biotechnology sector with its pioneering approach to genetic medicine. Based in Hayward, California, Benitec is at the forefront of developing transformative..

A2Z Cust2Mate Solutions Corp. (AZ) Investor Outlook: Exploring a Potential 381.54% Upside

A2Z Cust2Mate Solutions Corp. (AZ), a Canadian technology company, is poised for significant attention as it navigates the retail automation landscape. With an ambitious target price providing a potential upside..

Viant Technology Inc. (DSP) Stock Analysis: A Compelling 60% Upside Potential Beckons Investors

Viant Technology Inc. (NASDAQ: DSP) operates in the dynamic Technology sector, specifically within the Software – Application industry. Headquartered in Irvine, California, this advertising technology company is making waves with..

Grab Holdings Limited (GRAB): Investor Outlook with a 62% Potential Upside

Grab Holdings Limited (NASDAQ: GRAB), a leading player in the technology sector, is making waves with its promising potential upside of 62.34%. As a central figure in the software application..

Fulcrum Therapeutics, Inc. (FULC) Stock Analysis: An Ambitious Biotech with 92.93% Upside Potential

Fulcrum Therapeutics, Inc. (NASDAQ: FULC) stands at a pivotal moment in its journey as a clinical-stage biopharmaceutical company, with a notable potential upside of 92.93%. Established in 2015 and headquartered..

National Research Corporation (NRC): Valuation Insights and Market Positioning Amidst a Challenging Healthcare Sector

National Research Corporation (NRC), a key player in the Health Information Services industry, operates within the broader healthcare sector. Headquartered in Lincoln, Nebraska, NRC provides a range of analytics and..

XOMA Royalty Corporation (XOMA) Stock Analysis: Exploring a 139.69% Potential Upside in the Biotech Sector

XOMA Royalty Corporation (NASDAQ: XOMA), a key player in the biotechnology sector, offers investors a compelling opportunity with a projected potential upside of 139.69%. As a biotech royalty aggregator, XOMA..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds